Sort
16,300 grants matching “fatty liver disease”
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN (TONIC)
$9,754Jean Molleston · Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2007 · RR
Pioglitazone in NASH
$9,734University Of Chicago · M01 · FY2004 · RR
Liver Cancer (LC) (Project-003)
$9,671Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · P30 · FY2019 · CA
The Musculoskeletal Cost of Organ Repair
$9,580Leonidas G Koniaris · Indiana University Indianapolis · R01 · FY2021 · GM
Pilot Project
$9,402Pierre Michel Gholam · Cleveland Clinic Lerner Com-Cwru · P20 · FY2011 · AA
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism
$9,316Jonathan David Brown · Vanderbilt University Medical Center · K08 · FY2015 · HL
PATHOGENESIS OF ALCOHOL LIVER INJURY
$9,248University Of Southern California · R37 · FY2000 · AA
Obesity and Hepatic Steatosis
$9,199Michael J Pagliassotti · Colorado State University · R01 · FY2006 · DK
CLINICAL TRIAL: PHASE II TRIAL OF IDB 1016 IN ADULT DIABETIC PATIENTS WITH NASH
$9,058Heather Patton · University Of California, San Diego · M01 · FY2009 · RR
CDU Diversity-promoting Institutions Drug Abuse Research Development Program
$9,033Theodore C Friedman · Charles R. Drew University Of Med & Sci · R24 · FY2014 · DA
Regulation of Liver Growth and Function
$8,990Leonard S Jefferson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · DK
STUDY OF DIETARY CHANGES IN THE TREATMENT OF PEDIATRIC FATTY LIVER DISEASE
$8,682Peter F Whitington · Northwestern University At Chicago · M01 · FY2007 · RR
CDU Diversity-promoting Institutions Drug Abuse Research Development Program
$8,467Theodore C Friedman · Charles R. Drew University Of Med & Sci · R24 · FY2018 · DA
Novel Liver Signaling Pathways Controlling Adiposity
$8,390Terry D Hinds · University Of Toledo Health Sci Campus · R01 · FY2020 · DK
Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients
$8,172Chris Freise · University Of California, San Francisco · U01 · FY2014 · DK
Integrated Pathways of Disease in NASH and NAFLD
$8,000Thale Cross Jarvis · Keystone Symposia · R13 · FY2018 · DK
Mechanisms of differential susceptibility to nonalcoholic fatty liver disease
$7,933Jesse Daniel Riordan · Pacific Northwest Research Institute · F32 · FY2018 · DK
Circadian Clock Disruption: A Mechanism for Dioxin-induced Metabolic Syndrome
$7,857Shelley A Tischkau · Southern Illinois University Sch Of Med · R01 · FY2010 · ES
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$7,725Joannes B Hoek · Thomas Jefferson University · R01 · FY2010 · AA
The role of cAMP signaling changes in alcoholic liver disease
$7,662Victoria Lyell Prince · Univ Of Med/Dent Of Nj-Nj Medical School · F30 · FY2012 · AA
Caspase Dependent Cell Death in Nonalcoholic Fatty Liver Disease
$7,580Ariel Feldstein · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · DK
The Role of Alcohol in HIV Therapy Hepatotoxicity
$7,550Craig J McClain · University Of Louisville · R01 · FY2011 · AA
Chemistry and Biology of Carcinogen-DNA Adducts
$7,522Michael P Stone · Vanderbilt University · P01 · FY2007 · ES
Application for Research Supplement (diversity) for Kathryn A. Carbajal
$7,513Dudley William Lamming · University Of Wisconsin-Madison · R00 · FY2015 · AG
GENETICS OF PEDIATRIC NONALCOHOLIC FATTY LIVER DISEASE
$7,421Jeffrey B Schwimmer · University Of California, San Diego · M01 · FY2010 · RR